Clinical Trial Update: Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating humoral and cellular immunity of Tick Borne Encephalitis vaccination in allogeneic hematopoietic stem cell transplant recipients has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Snippet

Sponsor: Medical University of Vienna | Conditions: Tick Borne Encephalitis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-14